Publicacions (128) Publicacions de Ana María Estévez Braun

2023

  1. Labdane conjugates protect cardiomyocytes from doxorubicin-induced cardiotoxicity

    Drug Development Research, Vol. 84, Núm. 1, pp. 84-95

  2. Methyl esters of 23,24-Dinor-5α-cholan-22-oic acids as brassinosteroid Analogues. Synthesis, evaluation of plant growth promoting activity and Molecular docking

    Steroids, Vol. 196

  3. Phenolic and quinone methide nor-triterpenes as selective NLRP3 inflammasome inhibitors

    Bioorganic Chemistry, Vol. 132

  4. Synthesis and biological evaluation of anthracene-9,10 dione derivatives as CK2 inhibitors

    Results in Chemistry, Vol. 6

  5. Synthesis of Quinoline and Dihydroquinoline Embelin Derivatives as Cardioprotective Agents

    Journal of Natural Products, Vol. 86, Núm. 2, pp. 317-329

2022

  1. Dehydroisohispanolone as a Promising NLRP3 Inhibitor Agent: Bioevaluation and Molecular Docking

    Pharmaceuticals, Vol. 15, Núm. 7

  2. Design, Semisynthesis, and Estrogenic Activity of Lignan Derivatives from Natural Dibenzylbutyrolactones

    Pharmaceuticals, Vol. 15, Núm. 5, pp. 585

  3. Discovery of Highly Functionalized 5-hydroxy-2H-pyrrol-2-ones That Exhibit Antiestrogenic Effects in Breast and Endometrial Cancer Cells and Potentiate the Antitumoral Effect of Tamoxifen

    Cancers, Vol. 14, Núm. 21

2021

  1. Autodisplay of human PIP5K1α lipid kinase on Escherichia coli and inhibitor testing

    Enzyme and Microbial Technology, Vol. 143

  2. FLTX2: A Novel Tamoxifen Derivative Endowed with Antiestrogenic, Fluorescent, and Photosensitizer Properties

    International Journal of Molecular Sciences, Vol. 22, Núm. 10, pp. 5339

  3. JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia

    Biomedicine and Pharmacotherapy, Vol. 144

  4. Modular synthesis and antiproliferative activity of new dihydro-1H-pyrazolo[1,3-b]pyridine embelin derivatives

    Pharmaceuticals, Vol. 14, Núm. 10

  5. Synthesis and fungicidal activity of hydrated geranylated phenols against botrytis cinerea

    Molecules, Vol. 26, Núm. 22

2020

  1. Breakthroughs in medicinal chemistry: New targets and mechanisms, new drugs, new hopes-7

    Molecules, Vol. 25, Núm. 13

  2. Dehydrohispanolone Derivatives Attenuate the Inflammatory Response through the Modulation of Inflammasome Activation

    Journal of Natural Products, Vol. 83, Núm. 7, pp. 2155-2164

  3. Design, synthesis and biological evaluation of new embelin derivatives as CK2 inhibitors

    Bioorganic Chemistry, Vol. 95

  4. Development of an in vitro screening assay for PIP5K1α lipid kinase and identification of potent inhibitors

    FEBS Journal, Vol. 287, Núm. 14, pp. 3042-3064

  5. Efficient Multicomponent Synthesis of Diverse Antibacterial Embelin-Privileged Structure Conjugates

    Molecules (Basel, Switzerland), Vol. 25, Núm. 14

  6. Preparation of new metallic complexes from 2-hydroxy-3-((5-methylfuran-2-yl)methyl)-1,4-naphthoquinone

    Polyhedron, Vol. 177

2019

  1. A novel naphthoquinone-coumarin hybrid that inhibits BCR-ABL1-STAT5 oncogenic pathway and reduces survival in imatinib-resistant chronic myelogenous leukemia cells

    Frontiers in Pharmacology, Vol. 9, Núm. JAN